From: Adverse infusion reactions to rituximab in systemic lupus erythematosus: a retrospective analysis
Immediate Hypersensitivity | Delayed Hypersensitivity | Total | |||||
---|---|---|---|---|---|---|---|
Cycle Number | Unlikely immune mediated | Likely cytokine release | Likely immunoglobulin mediated | Bone pain | Early (24–48 h) | Late (> 48 h) | |
1 | 1 | 2 | 3 | 2 | 1 | 1 | 10 |
2 | 2 | 3 | 1 | 3 | 9 | ||
3 | 2 | 1 | 1 | 4 | |||
4 | |||||||
5 | |||||||
6 | 1 | 1 | |||||
Total | 4 | 7 | 5 | 2 | 1 | 5 | 24 |